Michael Scolaro

Michael Scolaro

Aug 28, 2017

Group 6 Copy 187
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Nepalese shrines and parks: hotspots for pathogen exchange between primates and humans?

    In Nepal people and primates come into close contact where humans both intentionally and unintentionally feed...

    Physical experience of emotion: an early marker of Parkinson's Disease?

    At least a decade before diagnosis with Parkinson's, the disease is transforming the way the mind and the body...

    Crowdcuring the Blues: People, Technology and Research Against Depression

    Depression is not a choice, but we can choose to do something about it. Depression is a single label used...

    Backer Badge Funded